Epkinly

epcoritamab-bysp

Approval

ApplicationBLA 761324
Approval dateMay 19, 2023
Approval year2023
SponsorGenmab Us, INC.

FDA-approved use

To treat relapsed or refractory diffuse large B-cell lymphoma (not otherwise specified) and high-grade B-cell lymphoma after two or more lines of systemic therapy

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Epkinly: